Your Gateway to GMP Compliance and Pharmaceutical Excellence
The Future of PIC/S in Regulatory Convergence How PIC/S Is Shaping the Future of Regulatory Convergence in GMP Oversight As pharmaceutical manufacturing becomes more complex and globally distributed, the need for consistent regulatory oversight across jurisdictions has never been greater. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) has played a vital role in promoting harmonized GMP…
Label Cleaning Equipment with Area of Use to Prevent Cross-Contamination Label All Cleaning Equipment to Identify Its Area of Use Remember: Cleaning tools must be visibly labeled with designated areas to prevent their misuse and reduce the risk of cross-contamination in GMP zones. Why This Matters in GMP Cleaning tools such as mops, buckets, wipes,…
Read More “Label Cleaning Equipment with Area of Use to Prevent Cross-Contamination” »
Case Study: PIC/S Impact on National GMP Strengthening Case Study: How PIC/S Membership Strengthened National GMP Systems National regulatory authorities play a pivotal role in ensuring drug quality and patient safety. However, disparities in GMP enforcement often emerge due to limited capacity, inconsistent guidance, or lack of global alignment. The Pharmaceutical Inspection Co-operation Scheme (PIC/S)…
Read More “Case Study: PIC/S Impact on National GMP Strengthening” »
Inspectorate Exchange Programs Under PIC/S How PIC/S Inspectorate Exchange Programs Promote Global GMP Harmonization Global consistency in GMP inspection practices is critical to ensuring the safety, efficacy, and quality of pharmaceutical products. Recognizing this, the Pharmaceutical Inspection Co-operation Scheme (PIC/S) established Inspectorate Exchange Programs to foster harmonized understanding, mutual learning, and inspection quality across its…
Never Overlook Documentation Steps During GMP Change Control Do Not Skip Documentation Steps in Change Control Processes Remember: All GMP change control steps—from initiation to closure—must be fully documented to ensure traceability, accountability, and regulatory compliance. Why This Matters in GMP Change control is a formal GMP system used to evaluate, approve, and implement modifications…
Read More “Never Overlook Documentation Steps During GMP Change Control” »
Benefits of PIC/S for Contract Manufacturers and CROs How PIC/S Strengthens GMP Oversight for Contract Manufacturers and CROs In today’s globalized pharmaceutical landscape, companies increasingly rely on Contract Manufacturing Organizations (CMOs) and Contract Research Organizations (CROs) to meet production, testing, and development needs. This outsourcing trend introduces complex compliance challenges, especially concerning Good Manufacturing Practice…
Read More “Benefits of PIC/S for Contract Manufacturers and CROs” »
GMP Audit Trends Observed in PIC/S Annual Reports Key GMP Audit Trends Revealed in PIC/S Annual Reports As global regulatory scrutiny intensifies, pharmaceutical manufacturers increasingly rely on insights from regulatory bodies to benchmark and improve compliance. The Pharmaceutical Inspection Co-operation Scheme (PIC/S) publishes annual reports that detail audit activities across its member countries. These reports…
Read More “GMP Audit Trends Observed in PIC/S Annual Reports” »
Ensure Tightness of Primary Packaging Before Dispatch in GMP Verify Primary Packaging Tightness Prior to Dispatch Remember: Before dispatch, ensure all primary packaging is intact, leak-proof, and properly sealed to comply with GMP packaging integrity standards. Why This Matters in GMP Primary packaging serves as the first line of defense against environmental contaminants, physical damage,…
Read More “Ensure Tightness of Primary Packaging Before Dispatch in GMP” »
Advanced Therapies and Biologics in the PIC/S Inspection Model How PIC/S Tailors Inspections for Advanced Therapies and Biologics Biologics and advanced therapy medicinal products (ATMPs) such as gene therapy, cell therapy, and tissue-engineered products are transforming modern medicine. These complex products pose unique Good Manufacturing Practice (GMP) challenges, requiring specialized regulatory oversight. The Pharmaceutical Inspection…
Read More “Advanced Therapies and Biologics in the PIC/S Inspection Model” »
Never Open Both Airlock Doors Simultaneously in GMP Cleanrooms Never Open Airlock Doors Simultaneously in Classified GMP Zones Remember: Simultaneous opening of airlock doors breaks pressure barriers, causing contamination—always follow interlock protocols or manual SOPs. Why This Matters in GMP Airlocks are buffer zones between cleanroom areas of different grades and serve as critical barriers…
Read More “Never Open Both Airlock Doors Simultaneously in GMP Cleanrooms” »
Don’t leave empty-handed. Watch practical GMP scenarios, inspection lessons, deviations, CAPA thinking, and real compliance insights on our YouTube channel. One click now can save you hours later.